Skip to main content

Saturday, July 20:  All UR Medicine facilities are open as scheduled and providing safe patient care, with a goal to return all clinical services to full efficiency by early next week.
Patients: click here for more information. Faculty/Staff: click here for information.


DRO2001 / RGUP20045 / Prostate HDR Brachy / Hong Zhang

Research Question:
Can men who have prostate cancer and have previously been treated with radiation therapy be treated high-dose-rate (HDR) brachytherapy if their cancer recurs?

Basic Study Information

The purpose of this study is to learn more about what effects the use of high-dose-rate (HDR) brachytherapy on prostate cancer recurrence, seen by AXUMIN PET scan, has on prostate cancer.

Location: University of Rochester
Study Reference #: RSRB00005667

Lead Researcher (Principal Investigator)

Lead Researcher:  Hong Zhang

Study Contact Information

Study Contact: Clinical Trials Office
Study Location: Wilmot Cancer Institute, University of Rochester Medical Center
Study Email:

Additional Study Details

Learn More About These Conditions

More information about Prostate Cancer

Contact This Study

This field is required
This field is required
You must agree to be contacted to continue.

Return to Search